12:30-14:30 Wednesday, 26 April, 2017
Lunch Session- Novo Nordisk-Hall J
A New Horizon in the Treatment of the Cardio Metabolic Patient
Faculty: Hila Knobler, Naim Shechade
| Time | Topic | Speaker |
| 12:30-13:00 | Lunch first and main courses | |
| 13:00-13:30 | Beyond Glucose Control -
Liraglutide treatment in diabetes leading to CV risk reduction (LEADER® trial) | Hila Knobler |
13:30-13:55
| Beyond the SCALE – Liraglutide 3 mg in the treatment of obesity (SCALE® trial) | Naim Shechade |
13:55-14:10
| Q&A
| |
